These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 21840329

  • 1. Dehydroepiandrosterone-sulphate replacement improves the human plasma fatty acid profile in plasma of obese women.
    Gómez-Santos C, Larqué E, Granero E, Hernández-Morante JJ, Garaulet M.
    Steroids; 2011 Dec 11; 76(13):1425-32. PubMed ID: 21840329
    [Abstract] [Full Text] [Related]

  • 2. Differential effect of oral dehydroepiandrosterone-sulphate on metabolic syndrome features in pre- and postmenopausal obese women.
    Gómez-Santos C, Hernández-Morante JJ, Tébar FJ, Granero E, Garaulet M.
    Clin Endocrinol (Oxf); 2012 Oct 11; 77(4):548-54. PubMed ID: 22136516
    [Abstract] [Full Text] [Related]

  • 3. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M, Monteleone P, Casarosa E, Quirici B, Puccetti S, Bernardi F, Genazzani AD, Rovati L, Luisi M, Genazzani AR.
    Gynecol Endocrinol; 2000 Oct 11; 14(5):342-63. PubMed ID: 11109974
    [Abstract] [Full Text] [Related]

  • 4. Dehydroepiandrosterone modifies rat fatty acid composition of serum and different adipose tissue depots and lowers serum insulin levels.
    de Heredia FP, Larqué E, Zamora S, Garaulet M.
    J Endocrinol; 2009 Apr 11; 201(1):67-74. PubMed ID: 19144736
    [Abstract] [Full Text] [Related]

  • 5. Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women.
    Diamond P, Cusan L, Gomez JL, Bélanger A, Labrie F.
    J Endocrinol; 1996 Sep 11; 150 Suppl():S43-50. PubMed ID: 8943786
    [Abstract] [Full Text] [Related]

  • 6. Dehydroepiandrosterone-sulfate modifies human fatty acid composition of different adipose tissue depots.
    Hernandez-Morante JJ, Cerezo D, Cruz RM, Larque E, Zamora S, Garaulet M.
    Obes Surg; 2011 Jan 11; 21(1):102-11. PubMed ID: 20094820
    [Abstract] [Full Text] [Related]

  • 7. Dehydroepiandrosterone sulfate levels in women. Relationships with body mass index, insulin and glucose levels.
    Al-Harithy RN.
    Saudi Med J; 2003 Aug 11; 24(8):837-41. PubMed ID: 12939667
    [Abstract] [Full Text] [Related]

  • 8. Plasma adrenal androgens and risk of breast cancer in premenopausal women.
    Page JH, Colditz GA, Rifai N, Barbieri RL, Willett WC, Hankinson SE.
    Cancer Epidemiol Biomarkers Prev; 2004 Jun 11; 13(6):1032-6. PubMed ID: 15184260
    [Abstract] [Full Text] [Related]

  • 9. [Evaluation of the influence of sex hormones on homocysteine concentration in pre- and postmenopausal women].
    Bednarek-Tupikowska G, Tupikowski K, Bohdanowicz-Pawlak A, Bidzińska B, Szymczak J, Filus A, Kuliczkowska J, Milewicz A.
    Pol Merkur Lekarski; 2005 Feb 11; 18(104):189-91. PubMed ID: 17877128
    [Abstract] [Full Text] [Related]

  • 10. Endothelin levels decrease after oral and nonoral estrogen in postmenopausal women with increased cardiovascular risk factors.
    Wilcox JG, Hatch IE, Gentzschein E, Stanczyk FZ, Lobo RA.
    Fertil Steril; 1997 Feb 11; 67(2):273-7. PubMed ID: 9022602
    [Abstract] [Full Text] [Related]

  • 11. Dhea supplementation and cognition in postmenopausal women.
    Parsons TD, Kratz KM, Thompson E, Stanczyk FZ, Buckwalter JG.
    Int J Neurosci; 2006 Feb 11; 116(2):141-55. PubMed ID: 16393880
    [Abstract] [Full Text] [Related]

  • 12. The association of dehydroepiandrosterone, obesity, waist-hip ratio and insulin resistance with fatty liver in postmenopausal women--a hyperinsulinemic euglycemic insulin clamp study.
    Saruç M, Yüceyar H, Ayhan S, Türkel N, Tuzcuoglu I, Can M.
    Hepatogastroenterology; 2003 Feb 11; 50(51):771-4. PubMed ID: 12828082
    [Abstract] [Full Text] [Related]

  • 13. Circulating levels of neuroactive steroids in patients with binge eating disorder: a comparison with nonobese healthy controls and non-binge eating obese subjects.
    Monteleone P, Luisi M, De Filippis G, Colurcio B, Monteleone P, Genazzani AR, Maj M.
    Int J Eat Disord; 2003 Dec 11; 34(4):432-40. PubMed ID: 14566930
    [Abstract] [Full Text] [Related]

  • 14. The incorporation of marine n-3 PUFA into platelets and adipose tissue in pre- and postmenopausal women: a randomised, double-blind, placebo-controlled trial.
    Witt PM, Christensen JH, Ewertz M, Aardestrup IV, Schmidt EB.
    Br J Nutr; 2010 Aug 11; 104(3):318-25. PubMed ID: 20334707
    [Abstract] [Full Text] [Related]

  • 15. Long-term low-dose oral administration of dehydroepiandrosterone modulates adrenal response to adrenocorticotropic hormone in early and late postmenopausal women.
    Genazzani AR, Pluchino N, Begliuomini S, Stomati M, Bernardi F, Pieri M, Casarosa E, Palumbo M, Genazzani AD, Luisi M.
    Gynecol Endocrinol; 2006 Nov 11; 22(11):627-35. PubMed ID: 17145649
    [Abstract] [Full Text] [Related]

  • 16. The effect of estrogen plus progestin treatment on sleep: a randomized, placebo-controlled, double-blind trial in premenopausal and late postmenopausal women.
    Kalleinen N, Polo O, Himanen SL, Joutsen A, Polo-Kantola P.
    Climacteric; 2008 Jun 11; 11(3):233-43. PubMed ID: 18568788
    [Abstract] [Full Text] [Related]

  • 17. Endogenous androgen levels and well-being: differences between premenopausal and postmenopausal women.
    Bell RJ, Donath S, Davison SL, Davis SR.
    Menopause; 2006 Jun 11; 13(1):65-71. PubMed ID: 16607100
    [Abstract] [Full Text] [Related]

  • 18. The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women.
    Tworoger SS, Missmer SA, Eliassen AH, Spiegelman D, Folkerd E, Dowsett M, Barbieri RL, Hankinson SE.
    Cancer Epidemiol Biomarkers Prev; 2006 May 11; 15(5):967-71. PubMed ID: 16702378
    [Abstract] [Full Text] [Related]

  • 19. SHBG levels correlate with insulin resistance in postmenopausal women.
    Akin F, Bastemir M, Alkiş E, Kaptanoglu B.
    Eur J Intern Med; 2009 Mar 11; 20(2):162-7. PubMed ID: 19327605
    [Abstract] [Full Text] [Related]

  • 20. Enhanced circadian ACTH release in obese premenopausal women: reversal by short-term acipimox treatment.
    Kok P, Kok SW, Buijs MM, Westenberg JJ, Roelfsema F, Frölich M, Stokkel MP, Meinders AE, Pijl H.
    Am J Physiol Endocrinol Metab; 2004 Nov 11; 287(5):E848-56. PubMed ID: 15280154
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.